Ann: AGM Presentation, page-133

First 133 Last

Share
Profile

Follow
VivaLaVida

1,524 Posts.

3037

31/05/19

09:50

Post #: 38839591
Share

Originally posted by GCar ↑

Stuck in the past much?

Why WILL they fail?
Future.

Many of us are here because we see a very bright future, where we are producing 10ktpa or more. When? Not sure. Some years away. Exact timing impossible to predict. Exact timing doesn’t really matter too much. Upside massive.

Many hurdles to overcome. Many already sorted.
Critical technical derisking achieved.

Many naysayers have egg on face regarding our technical achievements so far.

We are working towards commercial success; the financing issues we face are not unique to our company. Dilution? Sure. Expected. JZ will minimise where possible. Good.

What the market players and share price does in the meantime is largely irrelevant. “Downtrend” is irrelevant to the progress of the business.
If such opportunities were so obvious, everyone would be rich.

If you have assessed the potential and risk and it’s not for you, that’s fine.
Want to convince us all it’s doomed? Bring some reasoning though coz sadly that’s rather lacking in all the FUD that keeps getting posted.
Agenda obvious!

Perhaps go and rescue that poor mob that invested heavily into ORE at $7.50..? They need saving. Lol.

It’s about the future. Some of us have remained very upbeat because we are looking years ahead. The rollercoaster sp in the meantime is unpredictable and largely irrelevant. Everyone knows all Li stocks have been hammered. “Downtrend” talk is irrelevant when trying to establish fundamental company potential.

WHY will the company fail?
Future?

Many of us have been here from much lower prices. The potential hasn’t changed. Derisking has only made it more likely.

Do you post on all the other stocks that are “rubbish” too. Must keep you busy. All that research into stocks you don’t hold but want to save the poor souls that do! How nice.
Agenda obvious!

Expand

BTW Gcar, not having a go at good yourself and others in your league.... I hope it was self apparent about the point I was trying to make??

AGY Price at posting: 6.9¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

SGP

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

PAM

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

RAD

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

First 133 Last

Add AGY (ASX) to my watchlist

(20min delay)
Last 3.5¢		Change -0.001(2.78%)		Mkt cap ! $50.95M

Open	High	Low	Value	Volume
3.6¢	3.7¢	3.5¢	$34.38K	956.6K

Buyers (Bids)

No.	Vol.	Price($)
13	1027636	3.5¢

Sellers (Offers)

Price($)	Vol.	No.
3.6¢	120922	2

View Market Depth

No.	Vol.	Price($)
13	1027636	0.035
19	2322844	0.034
11	1335333	0.033
3	920000	0.032
5	1039333	0.031

Price($)	Vol.	No.
0.036	120922	2
0.037	1652775	8
0.038	1965900	8
0.039	1028000	6
0.040	742375	4

Last trade - 16.10pm 19/11/2024 (20 minute delay)

AGY (ASX) Chart

Ann: AGM Presentation, page-133

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: AGM Presentation, page-133

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News